{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:45:35Z","timestamp":1783010735008,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["1409\u201321,688"],"award-info":[{"award-number":["1409\u201321,688"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jsat.2021.108355","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T22:50:58Z","timestamp":1615416658000},"page":"108355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Extended release injectable naltrexone before vs. after release: A randomized trial of opioid addicted persons who are in prison"],"prefix":"10.1016","volume":"127","author":[{"given":"George E.","family":"Woody","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmer","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin G.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jsat.2021.108355_bb0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1016\/j.jsat.2021.108355_bb0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison: A high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2021.108355_bb0015","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.jsat.2021.108355_bb0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.jsat.2021.108355_bb0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1360-0443.2007.02081.x","article-title":"Acute risk of drug related death among newly released prisoners in England and Wales","volume":"103","author":"Farrell","year":"2007","journal-title":"Addiction."},{"issue":"4","key":"10.1016\/j.jsat.2021.108355_bb0030","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/jurban\/jth147","article-title":"Jail management of arrestees\/inmates enrolled in community methadone maintenance programs","volume":"81","author":"Fiscella","year":"2004","journal-title":"Journal of Urban Health"},{"issue":"4","key":"10.1016\/j.jsat.2021.108355_bb0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0899-3289(01)00058-X","article-title":"Can the treatment services review be used to estimate the costs of addiction and ancillary services?","volume":"12","author":"French","year":"2000","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108355_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): Availability, barriers, and intentions","volume":"33","author":"Friedman","year":"2012","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2021.108355_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsat.2017.04.010","article-title":"Initiation of extended release naltrexone for opioid use disorder prior to release from prison","volume":"85","author":"Friedman","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"8","key":"10.1016\/j.jsat.2021.108355_bb0050","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1360-0443.2008.002238.x","article-title":"A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release","volume":"103","author":"Gordon","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2021.108355_bb0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsat.2015.07.005","article-title":"A phase 4, pilot, open-label study of XR-NTX (extended-release naltrexone XR-NTX) for prisoners","volume":"59","author":"Gordon","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2021.108355_bb0060","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","article-title":"Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system","volume":"75","author":"Green","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jsat.2021.108355_bb0065","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1360-0443.2011.03676.x","article-title":"The effectiveness of opioid maintenance in prison settings: A systematic review","volume":"107","author":"Hedrich","year":"2011","journal-title":"Addiction."},{"key":"10.1016\/j.jsat.2021.108355_bb0070","series-title":"Living in balance: Moving from a life of addiction to a life of recovery","author":"Hoffman","year":"2003"},{"key":"10.1016\/j.jsat.2021.108355_bb0075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0010-440X(93)90061-8","article-title":"The use of the DSM-III-R Checklist for initial diagnostic assessment","volume":"34","author":"Hudziak","year":"1993","journal-title":"Comprehensive Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.jsat.2021.108355_bb0080","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.drugalcdep.2007.05.022","article-title":"A randomized clinical trial of methadone maintenance for prisoners: Results at one-month post-release","volume":"91","author":"Kinlock","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2021.108355_bb0085","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsat.2009.03.002","article-title":"A randomized clinical trial of methadone maintenance for prisoners: Results at twelve-months post-release","volume":"37","author":"Kinlock","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108355_bb0090","series-title":"Textbook of substance abuse treatment","first-page":"251","article-title":"Opioids: detoxification","author":"Kleber","year":"1999"},{"key":"10.1016\/j.jsat.2021.108355_bb0095","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJMoa1505409","article-title":"Extended-release naltrexone to prevent opioid relapse in criminal justice offenders","volume":"374","author":"Lee","year":"2016","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.jsat.2021.108355_bb0100","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/add.12894","article-title":"Opioid treatment at release from jail using extended-release naltrexone: A pilot proof-of-concept randomized trial","volume":"110","author":"Lee","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2021.108355_bb0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jsat.2017.04.002","article-title":"Extended-release naltrexone for opioid use disorder started during or following incarceration","volume":"85","author":"Lincoln","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1\u20133","key":"10.1016\/j.jsat.2021.108355_bb0110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","article-title":"Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial","volume":"99","author":"Magura","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2021.108355_bb0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the addiction severity index","volume":"9","author":"McLellan","year":"1992","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"Suppl. 2","key":"10.1016\/j.jsat.2021.108355_bb0120","first-page":"S281","article-title":"An automated version of the risk assessment battery (RAB): Enhancing the assessment of risk behaviors","volume":"10","author":"Navaline","year":"1994","journal-title":"AIDS Research and Human Retroviruses"},{"key":"10.1016\/j.jsat.2021.108355_bb0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jclinepi.2017.02.010","article-title":"Simple randomization did not protect against bias in smaller trials","volume":"84","author":"Nguyen","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1016\/j.jsat.2021.108355_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010862.pub2","article-title":"Pharmacological interventions for drug-using offenders","author":"Perry","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2021.108355_bb0135","series-title":"Measuring alcohol consumption","article-title":"Timeline Follow-Back: A technique for assessing self-reported alcohol consumption","author":"Sobell","year":"2007"},{"key":"10.1016\/j.jsat.2021.108355_bb0140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/QAI.0000000000001634","article-title":"Extended-release naltrexone improves viral suppression among incarcerated persons living with HIV with opioid use disorders transitioning to the community: Results of a double-blind, placebo-controlled randomized trial","volume":"78","author":"Springer","year":"2018","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"12","key":"10.1016\/j.jsat.2021.108355_bb0145","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial","volume":"68","author":"Weiss","year":"2011","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1016\/j.jsat.2021.108355_bb0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The clinical opiate withdrawal scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"Journal of Psychoactive Drugs"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:54:12Z","timestamp":1760039652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221000817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":30,"alternative-id":["S0740547221000817"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108355","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extended release injectable naltrexone before vs. after release: A randomized trial of opioid addicted persons who are in prison","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108355"}}